Clinical trial results, published in The Journal of Neuroscienceby Eli Lilly & Co., suggest a promising new therapy for Alzheimer's disease.
Read More
U.Va. Health System Board Quality Subcommittee reflects on recent accomplishments
By Michael Racz | 3 days agoThe HSB Quality Subcommittee is responsible for overseeing clinical performance and performance improvement within the Health System.
U.Va. School of Medicine names two new department chairs, explains selection process
By Michael Racz | August 19, 2026In an interview with The Cavalier Daily, Colin Derdeyn, interim dean of the School of Medicine, explained the selection process of the two chairs and the new chairs’ plans for their departments.
Nursing Dean Marianne Baernholdt steps down amidst season of U.Va. Health leadership turnover
By Lauren Seeliger and Grace Little | August 18, 2026Brie Gertler, interim executive vice president and provost, and Dr. Mitchell Rosner, chief executive officer of U.Va. Health and executive vice president for health affairs, wrote to the School of Nursing community Tuesday morning to announce Nursing Dean Dr. Marianne Baernholdt will be stepping down from her role.
